课题基金 / 基金详情

The roles of the TAK1-Pim-2 pathway in drug resistance and bone destruction in multiple myeloma and development of novel agents to conquer them

The roles of the TAK1-Pim-2 pathway in drug resistance and bone destruction in multiple myeloma and development of novel agents to conquer them
TAK1-Pim-2 通路在多发性骨髓瘤耐药性和骨质破坏中的作用以及克服这些问题的新型药物的开发
批准号:
18K08329
负责人:
ABE Masahiro
金额:
$2.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2018
资助国家:
日本
项目状态:
已结题
起止时间:
2018-04-01 至 2022-03-31

项目摘要

项目成果

ABE Masahiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(28)
专著(0)
科研奖励(0)
会议论文
PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γ
帕比司他联合干扰素-γ 上调骨髓瘤细胞中的 PD-L1
DOI: --
发表时间: 2019
期刊: Oncotarget
影响因子: --
作者: [Iwasa M, Harada T, Oda A, Bat-Erdene A, Teramachi J, TenshinT, Ashtar M, Oura M, Sogabe K, Udaka K, Fujii S, Nakamura S, Miki H, Kagawa K, Ozaki S and Abe M]
通讯作者: Ozaki S and Abe M
DOI: 10.3390/cancers12010012
发表时间: 2020-01-01
期刊: CANCERS
影响因子: 5.2
作者: [Ozaki, Shuji, Harada, Takeshi, Abe, Masahiro]
通讯作者: Abe, Masahiro
Effect of serum concentration and concomitant drugs on vancomycin-induced acute kidney injury in haematologic patients: a single-centre retrospective study
血液病患者血清浓度及合并用药对万古霉素所致急性肾损伤的影响:单中心回顾性研究
DOI: 10.1007/s00228-019-02756-4
发表时间: 2019
期刊: Eur J Clin Pharmacol
影响因子: 2.9
作者: [Okada N, Chuma M, Azuma M, Nakamura S, Miki H, Hamano H, Goda M, Takechi K, Zamami Y, Abe M, Ishizawa K]
通讯作者: Ishizawa K
DOI: 10.1073/pnas.1815166116
发表时间: 2019-06-04
期刊: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
影响因子: 11.1
作者: [Takashi, Yuichi, Kosako, Hidetaka, Fukumoto, Seiji]
通讯作者: Fukumoto, Seiji
19
    Mechanisms of myeloma growth in bone marrow microenvironment and development of novel therapeutic options for myeloma
    • 批准号:
      26461422
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2014
    • 负责人:
      ABE Masahiro
    • 依托单位:
    Mechanisms of bone destruction and drug resistance in myeloma: a novel therapeutic strategy targeting a myeloma-bone marrow interaction
    • 批准号:
      23591390
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2011
    • 负责人:
      ABE Masahiro
    • 依托单位:
    The Effect of Gender Equality Policy on the Labor Market in Japan
    • 批准号:
      20330051
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.15万
    • 财政年份:
      2008
    • 负责人:
      ABE Masahiro
    • 依托单位:
    Identification and clinical application of osteoclast-derived growth factors for myeloma
    • 批准号:
      15591010
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2003
    • 负责人:
      ABE Masahiro
    • 依托单位:
    海外基金